ProCE Banner Activity

My Thoughts on the Evolving Landscape of PARP Inhibitors and the Role of Biomarkers in Ovarian Cancer

Clinical Thought
Read this expert commentary to gain practical clinical insights on the current treatment landscape of PARP inhibitors and the role of biomarkers in ovarian cancer.

Released: November 02, 2021

Expiration: November 01, 2022

No longer available for credit.



Nicoletta Colombo

Nicoletta Colombo, MD

Professor of Obstetrics and Gynecology
University of Milan-Bicocca
European Institute of Oncology
Milan, Italy

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner


Supported by an educational grant from